BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28186686)

  • 21. Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development.
    Khedoe PPSJ; de Kleijn S; van Oeveren-Rietdijk AM; Plomp JJ; de Boer HC; van Pel M; Rensen PCN; Berbée JFP; Hiemstra PS
    PLoS One; 2017; 12(9):e0183741. PubMed ID: 28910300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report.
    Park TS; Hong Y; Lee JS; Oh SY; Lee SM; Kim N; Seo JB; Oh YM; Lee SD; Lee SW
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1501-11. PubMed ID: 26251590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy.
    Valipour A; Herth FJ; Burghuber OC; Criner G; Vergnon JM; Goldin J; Sciurba F; Ernst A;
    Eur Respir J; 2014 Feb; 43(2):387-96. PubMed ID: 23845721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction.
    Keller CA; Gonwa TA; Hodge DO; Hei DJ; Centanni JM; Zubair AC
    Stem Cells Transl Med; 2018 Feb; 7(2):161-167. PubMed ID: 29322685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter trial of an intrabronchial valve for treatment of severe emphysema.
    Wood DE; McKenna RJ; Yusen RD; Sterman DH; Ost DE; Springmeyer SC; Gonzalez HX; Mulligan MS; Gildea T; Houck WV; Machuzak M; Mehta AC
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):65-73. PubMed ID: 17198782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic human umbilical cord-derived mesenchymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case-control, phase I/II trial.
    Hoang DM; Nguyen KT; Nguyen AH; Nguyen BN; Nguyen LT
    BMJ Open; 2021 May; 11(5):e045788. PubMed ID: 33986057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways.
    Gu W; Song L; Li XM; Wang D; Guo XJ; Xu WG
    Sci Rep; 2015 Mar; 5():8733. PubMed ID: 25736434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension.
    Eberhardt R; Gerovasili V; Kontogianni K; Gompelmann D; Ehlken N; Herth FJ; Grünig E; Nagel C
    Respiration; 2015; 89(1):41-8. PubMed ID: 25502235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®).
    Herth FJ; Gompelmann D; Stanzel F; Bonnet R; Behr J; Schmidt B; Magnussen H; Ernst A; Eberhardt R
    Respiration; 2011; 82(1):36-45. PubMed ID: 21228545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.
    Liu HM; Liu YT; Zhang J; Ma LJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):496-504. PubMed ID: 28786060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema.
    Antunes MA; Abreu SC; Cruz FF; Teixeira AC; Lopes-Pacheco M; Bandeira E; Olsen PC; Diaz BL; Takyia CM; Freitas IP; Rocha NN; Capelozzi VL; Xisto DG; Weiss DJ; Morales MM; Rocco PR
    Respir Res; 2014 Oct; 15(1):118. PubMed ID: 25272959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.
    Sciurba FC; Criner GJ; Strange C; Shah PL; Michaud G; Connolly TA; Deslée G; Tillis WP; Delage A; Marquette CH; Krishna G; Kalhan R; Ferguson JS; Jantz M; Maldonado F; McKenna R; Majid A; Rai N; Gay S; Dransfield MT; Angel L; Maxfield R; Herth FJ; Wahidi MM; Mehta A; Slebos DJ;
    JAMA; 2016 May 24-31; 315(20):2178-89. PubMed ID: 27179849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of physical activity after endobronchial valve treatment in emphysema patients.
    Hartman JE; Klooster K; Slebos DJ; Ten Hacken NH
    Respir Med; 2016 Aug; 117():116-21. PubMed ID: 27492521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical review: Endobronchial valve treatment for emphysema.
    Jarad N
    Chron Respir Dis; 2016 May; 13(2):173-88. PubMed ID: 26879696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Imaging in Bronchoscopic Lung Volume Reduction Using Endobronchial Valve: State of the Art Review.
    Dass C; Goldbach A; Dako F; Kumaran M; Steiner R; Criner GJ
    J Thorac Imaging; 2021 May; 36(3):131-141. PubMed ID: 32740228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up.
    Kontogianni K; Gerovasili V; Gompelmann D; Schuhmann M; Heussel CP; Herth FJ; Eberhardt R
    Respiration; 2014; 88(1):52-60. PubMed ID: 24819548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow up after endoscopic valve therapy in patients with severe emphysema.
    Gompelmann D; Heinhold T; Rötting M; Bischoff E; Kontogianni K; Eberhardt R; Herth FJF
    Ther Adv Respir Dis; 2019; 13():1753466619866101. PubMed ID: 31373259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic obstructive pulmonary disease.
    Jin Z; Pan X; Zhou K; Bi H; Wang L; Yu L; Wang Q
    J Int Med Res; 2015 Jun; 43(3):303-10. PubMed ID: 25834280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
    Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
    Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.